| Type 1 Diabetes Mellitus |
1 |
1 |
| Hypoglycemia |
0 |
0.99 |
| Clinical Guidelines |
0 |
0.98 |
| Insulin Pump |
0 |
0.2 |
| Type 2 Diabetes Mellitus |
0 |
0.16 |
| Revenue and Practice Management |
0 |
0.11 |
| Child |
0 |
0.1 |
| Endocrine Society |
0 |
0.1 |
| Stress |
0 |
0.1 |
| Patient Safety |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.09 |
| Drug Reaction |
0 |
0.07 |
| Endocrinology |
0 |
0.07 |
| Health Education and Counseling |
0 |
0.07 |
| Inpatient Care |
0 |
0.07 |
| Metabolism |
0 |
0.07 |
| Salary and Compensation |
0 |
0.07 |
| Adverse Effects |
0 |
0.03 |
| Blood |
0 |
0.03 |
| California |
0 |
0.03 |
| Caregiver |
0 |
0.03 |
| Insulin Analog |
0 |
0.03 |
| Insulin Therapy |
0 |
0.03 |
| Insurance |
0 |
0.03 |
| Match |
0 |
0.03 |
| Medicare |
0 |
0.03 |
| Patient Assessment |
0 |
0.03 |
| Quality of Life |
0 |
0.03 |
| Seizure |
0 |
0.03 |
| Shared Decision-Making |
0 |
0.03 |
| Socioeconomics |
0 |
0.03 |
| Virginia |
0 |
0.03 |